Legal Representation
Attorney
Natalie Albrecht
USPTO Deadlines
Next Deadline
39 days remaining
NOA E-Mailed - SOU Required
Due Date
September 11, 2025
Extension Available
Until March 11, 2026
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 19, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 18, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 18, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 18, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 10, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 25, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 23, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 20, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-infectives; veterinary pharmaceutical preparations for treatment of ophthalmic disease; pharmaceutical preparations for ophthalmic use; medicinal preparations and pharmaceutical substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for the treatment of ocular surface diseases; pharmaceutical preparations for use in dermatology; medicated preparations for skin treatment; antimicrobials for dermatologic use; anti-dermoinfectives; pharmaceutical preparations for dental use; pharmaceutical preparations for the treatment of posterior eye diseases; pharmaceutical preparations for topical use for treating dermatologic conditions; pharmaceutical water-free preparations (exclusive medicaments, medicines), namely aids in the nature of veterinary pharmaceutical preparations for topical treatment of eye diseases and disorders and active substances comprising semifluorinated alkanes (SFAs) being medical aids.
Class 042
Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; scientific and technological consultancy relating to the syntheses and production of pharmaceuticals; clinical research in the fields of ophthalmic pharmaceutical preparations, dermatologic pharmaceutical preparations, semifluorinated alkanes (SFAs) and of topical medical treatments; testing, authentication and quality control for others in the field of semifluorinated alkanes (SFAs) and of water-free pharmaceutical preparations.
Additional Information
Design Mark
The mark consists of the wording "NOVALIQ" displayed in stylized characters in blue color.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Classification
International Classes
005
042